• 8 Hits
  • Search Condition : Filter (MeSH = Non-alcoholic Fatty Liver Disease / pathology)
Species Resource Title
Human and Animal Cells Hep G2 IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism.
Human and Animal Cells CACO-2(RCB0988) A Lipid-Based Nanocarrier Containing Active Vitamin D3 Ameliorates NASH in Mice via Direct and Intestine-Mediated Effects on Liver Inflammation.
Human and Animal Cells RAW 264(RCB0535) Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
Mice RBRC01828 Ablation of Iah1, a candidate gene for diet-induced fatty liver, does not affect liver lipid accumulation in mice.
Human and Animal Cells RAW 264(RCB0535) Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects.
Human and Animal Cells KUP5(RCB4627) Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
Human and Animal Cells Hepa 1-6(RCB1638) Mice in the early stage of liver steatosis caused by a high fat diet are resistant to thioacetamide-induced hepatotoxicity and oxidative stress.
Human and Animal Cells RAW 264(RCB0535) Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis.